These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Therapeutic trials of multiple sclerosis and intrathecal IgG production. Wender M, Tokarz E, Michalowska G, Wajgt A. Ital J Neurol Sci; 1986 Apr; 7(2):205-8. PubMed ID: 3013800 [Abstract] [Full Text] [Related]
23. Immunosuppression: promises and failures. Oger J. J Neurol Sci; 2007 Aug 15; 259(1-2):74-8. PubMed ID: 17382964 [Abstract] [Full Text] [Related]
24. [Immunosuppressive treatment im multiple sclerosis]. Mertin J. Fortschr Med; 1980 Oct 02; 98(37):1431-6. PubMed ID: 6253370 [Abstract] [Full Text] [Related]
25. Medications used in the treatment of multiple sclerosis. Schapiro RT. Phys Med Rehabil Clin N Am; 1999 May 02; 10(2):437-46, ix. PubMed ID: 10370939 [Abstract] [Full Text] [Related]
26. A double blind, placebo-controlled, phase II, add-on study of cyclophosphamide (CTX) for 24 months in patients affected by multiple sclerosis on a background therapy with interferon-beta study denomination: CYCLIN. Patti F, Amato MP, Filippi M, Gallo P, Trojano M, Comi GC. J Neurol Sci; 2004 Aug 15; 223(1):69-71. PubMed ID: 15261564 [Abstract] [Full Text] [Related]
27. [Intensive immunosuppressive treatment of chronic progressive multiple sclerosis]. Hommes OR. Ned Tijdschr Geneeskd; 1978 Oct 14; 122(41):1545-51. PubMed ID: 358004 [No Abstract] [Full Text] [Related]
28. [Immunosuppressive treatment of multiple sclerosis (review of the literature]. Neretin VIa, Kir'iakov VA, Sapfirova VA. Zh Nevropatol Psikhiatr Im S S Korsakova; 1990 Oct 14; 90(2):119-26. PubMed ID: 2160156 [No Abstract] [Full Text] [Related]
30. Immunosuppressive drugs in multiple sclerosis: pro and con. Ellison GW, Myers LW. Neurology; 1980 Jul 14; 30(7 Pt 2):28-32. PubMed ID: 6248818 [No Abstract] [Full Text] [Related]
31. [Late results of the treatment of the chronic progressive form of multiple sclerosis by intensive immunosuppression]. Wender M, Tokarz-Kupczyk E, Mularek O. Neurol Neurochir Pol; 1989 Jul 14; 23(3):188-92. PubMed ID: 2561379 [Abstract] [Full Text] [Related]
32. The peculiar difficulties of therapeutic trials for multiple sclerosis. Myers LW, Ellison GW. Neurol Clin; 1990 Feb 14; 8(1):119-41. PubMed ID: 1690838 [Abstract] [Full Text] [Related]
37. [Immunosuppressive medication in multiple sclerosis]. García Merino JA. Rev Neurol; 2011 Dec 14; 35(12):1154-8. PubMed ID: 12497298 [Abstract] [Full Text] [Related]
38. [Critic study of multiple sclerosis treatment by chlorambucil and intraspinal corticotherapy. Apropos of 100 cases followed up from 2 to 9 years]. Sigwald J, Mazalton A, Raymondeaud C, Piot C, Jacquillat C. Rev Neurol (Paris); 1973 Jan 14; 128(1):72-7. PubMed ID: 4367744 [No Abstract] [Full Text] [Related]
39. [Immunosuppressants and multiple sclerosis]. Ruiz-Peña JL, Izquierdo-Ayuso G. Rev Neurol; 1973 Jan 14; 35(4):373-80. PubMed ID: 12235571 [Abstract] [Full Text] [Related]
40. Current methods of therapy in multiple sclerosis. Sibley WA. Mod Treat; 1970 Sep 14; 7(5):918-29. PubMed ID: 4326377 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]